Drug intelligence / Profile preview

Noah Tech stem cell therapy

Development stage: Preclinical
Lead developer: DR.Noah Biotech
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

Noah Tech, Corp. is developing a proprietary mesenchymal stem cell (MSC) therapy for the treatment of mild cognitive impairment (MCI). The therapy involves the administration of autologous or allogeneic stem cells via intravenous or targeted delivery routes. It is designed to promote neuroregeneration, enhance neuroplasticity, and repair damaged brain cells to slow the progression of cognitive decline in adults aged 55 and older. This biologic intervention is currently being evaluated in the MCITestCare clinical trial (NCT07214974), a multi-arm study that also investigates the integration of wearable brain-computer interface (BCI) devices and community-based screening to improve cognitive outcomes.

Other names: mesenchymal stem cellsMSCsautologous stem cellsallogeneic stem cells

Beyond the preview

Go deeper on Noah Tech stem cell therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noah Tech stem cell therapy.

Explore the full profile